Entering the US market I: Market Introduction

As part of the Health3-2-1 project, we invite you to our first US market event, where we will cover the essentials of the US life science and healthcare market and with presentations from the states of Virginia, Maryland and Massachusetts (tbc). 

Date: 24.10.2024
Time: 15:00-16:00 CET/Sweden  - 16:00-17:00 EET /Finland and Estonia
Location: ONLINE 

Whether you’re a business leader, entrepreneur, or SME looking to expand into the US, this session is designed to offer valuable insights tailored to the life sciences sectors (HealthTech, MedTech, BioTech, and Pharma).

15:00/16:00 Opening words
Welcoming remarks and introduction to the seminar. Short overview of Health3-2-1 project. Presenters: Ulf Borbos and Anna Riby

15:10/16:10 Overview of the US health care and life science market
An analysis of the UK market, including economic indicators, growth sectors, and trends relevant to SMEs. Presenter: Claudia Hidou, Head of New York and Head of Life Science & Healthcare för Business Sweden Americas

15:30/16:30 Direct Investment Opportunities in the Virginia Life Sciences Market
Virginia's life sciences ecosystem spans the entire value chain, including public and private R&D, laboratories that provide testing and other services. Virginia is also ranked in the Top 10 for healthcare quality. Presenter: Grace Festa, Director, Biopharmaceuticals, Virginia Economic Development Partnership

15:40/16:40 Health and Life Science in Maryland
With one of the nation's largest clusters, a community of over 2,700 life science businesses and top-level hospitals, Maryland also has unparalleled proximity to leading federal institutions such as the National Institutes of Health, National Institute of Standards and Technology and the Food and Drug Administration. Presenter: Stefanie Trop, Director, Office of Life Sciences at Maryland Department of Commerce

15:50/16:50 Health and Life Science in Massachusetts - TBC
Massachusetts is the global epicenter for the life sciences industry with some 1,200 companies. It is also home to some of the most prestigious hospitals globally.

16:00/17:00 Open discussion and final remarks
Opportunity for participants to ask additional questions or discuss topics further

16:15/17:15 End of program

The session will be recorded, and all registered participants will receive a copy after the event.

Health3-2-1 is an EU Interreg-funded project led by Tehnopol Science and Business Park (EE), Business Turku (FI), and Swecare (SE). The project aims to support small and medium-sized enterprises in the life sciences sector as they expand into export markets in the UK (London) and the US (Massachusetts or the Washington Metropolitan Area).

Selected companies will receive a comprehensive support package valued at up to €20,000, including tailored mentoring, thematic seminars, and up to two business missions to the target markets.

A limited number of companies will be selected to participate and receive support in reaching active sales.
 

If you have questions about the webinars, don't hesitate to email us:
Ulf Borbos: ulf.borbos@swecare.se
Anna Riby: anna.riby@swecare.se
Tero Piisplanen: ero.piispanen@businessturku.fi